CASELLI, Emilia
 Distribuzione geografica
Continente #
NA - Nord America 6.956
AS - Asia 3.496
EU - Europa 3.402
SA - Sud America 471
AF - Africa 63
OC - Oceania 5
Totale 14.393
Nazione #
US - Stati Uniti d'America 6.847
SG - Singapore 1.117
CN - Cina 1.111
IT - Italia 902
GB - Regno Unito 791
SE - Svezia 505
HK - Hong Kong 427
BR - Brasile 378
DE - Germania 233
VN - Vietnam 232
RU - Federazione Russa 191
KR - Corea 159
UA - Ucraina 152
FI - Finlandia 129
TR - Turchia 119
FR - Francia 101
IN - India 74
BG - Bulgaria 63
CA - Canada 59
BE - Belgio 57
ID - Indonesia 55
JP - Giappone 51
NL - Olanda 51
IE - Irlanda 49
PL - Polonia 42
BD - Bangladesh 40
MX - Messico 39
ES - Italia 33
RO - Romania 30
AR - Argentina 29
ZA - Sudafrica 20
AT - Austria 18
IQ - Iraq 16
LT - Lituania 16
MA - Marocco 15
EC - Ecuador 14
MY - Malesia 13
CL - Cile 12
CO - Colombia 12
AE - Emirati Arabi Uniti 9
PK - Pakistan 9
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
AZ - Azerbaigian 7
KZ - Kazakistan 7
TW - Taiwan 7
PE - Perù 6
DZ - Algeria 5
MD - Moldavia 5
SC - Seychelles 5
CH - Svizzera 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
NO - Norvegia 4
PH - Filippine 4
PY - Paraguay 4
TN - Tunisia 4
AL - Albania 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EG - Egitto 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
QA - Qatar 3
AU - Australia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EE - Estonia 2
GY - Guiana 2
KG - Kirghizistan 2
LV - Lettonia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
AM - Armenia 1
CG - Congo 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
LU - Lussemburgo 1
MT - Malta 1
NR - Nauru 1
OM - Oman 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
Totale 14.391
Città #
Santa Clara 760
Singapore 691
Ashburn 565
Chandler 517
Fairfield 475
Hefei 454
Woodbridge 448
Hong Kong 420
Southend 419
Jacksonville 303
Ann Arbor 263
Nyköping 262
Houston 238
London 208
Dearborn 206
Seattle 195
Cambridge 192
Wilmington 190
Modena 172
Beijing 152
Dallas 127
Los Angeles 118
Chicago 104
Seoul 101
Helsinki 77
Ho Chi Minh City 74
Council Bluffs 72
San Jose 71
The Dalles 62
Princeton 61
Sofia 61
New York 58
Hanoi 54
Milan 54
San Diego 53
Redwood City 52
Eugene 48
Des Moines 47
Shanghai 47
Dublin 46
São Paulo 42
Izmir 41
Jakarta 39
Moscow 38
Salt Lake City 38
Reggio Emilia 37
Brussels 36
Tokyo 34
Buffalo 33
Parma 32
Warsaw 32
Amsterdam 29
Munich 28
Yalova 28
Bologna 27
Frankfurt am Main 26
Phoenix 25
Brooklyn 23
Elk Grove Village 21
Florence 21
Tampa 21
Timisoara 21
Boardman 20
Mexico City 20
Turin 20
Columbus 19
Falls Church 19
Menlo Park 19
Nuremberg 19
Guangzhou 18
Pedara 18
Fuzhou 17
Bremen 16
Fremont 16
Kent 16
Chennai 15
Formigine 15
Orem 15
Seongnam 15
Atlanta 14
Boston 14
Denver 14
Dong Ket 14
Ghent 14
Washington 14
Norwalk 13
Johannesburg 12
Redondo Beach 12
San Francisco 12
Toronto 12
Vancouver 12
Kunming 11
Montreal 11
Nanjing 11
Rio de Janeiro 11
Rome 11
Salvador 11
Poplar 10
Pune 10
Verona 10
Totale 9.739
Nome #
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening 895
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase 614
Chemo-enzymatic synthesis of levodropropizine 348
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 343
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors 340
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa 326
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design 316
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols 308
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii 297
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes 290
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030 283
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases 282
Sintesi Stereoselettiva di Acidi Boronici Inibitori di beta-Lattamasi 279
Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs) 265
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 265
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors 252
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method 249
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 249
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli 246
One-Pot Synthesis of Imidazole-4-Carboxylates by Microwave-Assisted1,5-Electrocyclization of Azavinyl Azomethine Ylides 241
Sulfonamido-substituted boronic acids as β-lactamase inhibitors for treatment of antibiotic-resistant bacterial infections 235
α-Aminoester-Derived Imidazoles by 1,5-Electrocyclization of Azavinyl Azomethine Ylides 235
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 234
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii 230
Negative Epistasis and Evolvability in TEM-1 β-Lactamase—The Thin Line between an Enzyme's Conformational Freedom and Disorder 225
Lipase-Catalyzed Resolution and Desymmetrization of 2-Hydroxymethylaziridines 224
Inhibition of Acinetobacter -Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors 222
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase 219
Straightforward synthesis of chiral non-racemic α-boryl isocyanides 216
Structure-based design and in-parallel synthesis of inhibitors of AmpC β-lactamase 212
Highly enantioselective reduction of ethyl 4-chloro-3-oxobutanoate to L-and D-3-hydroxyesters with baker`s yeast 208
Nanomolar inhibitors of AmpC beta-lactamase 206
Exploring sequence requirements for C3/C4 carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase 205
Fragment-guided Design of Subnanomolar β-Lactamase Inhibitors Active in vivo 205
Synthesis of [(1,2,3-Triazol-1-yl)methyl]boronic Acids Through Click Chemistry: Easy Access to a Potential Scaffold for Protease Inhibitors 203
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor. 198
Using Boronic Acid Transition State Inhibitors to understand the extended spectrum (ES) and carbapenemase phenotypes of class A beta-lactamases in Klebsiella pneumoniae 197
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses 192
Structure-based optimization of cephalotin analogue boronic acids as beta-lactamase inhibitors 192
The structures of Ceftazidime and Its Transition State Analog in Complex with AmpC-beta-lactamase: Implication for Resistance Mutation and Inhibitor Design 191
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase 191
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 184
Exploring novel inhibitors of FOX-4 Class C β-lactamase 183
Stereoselective synthesis of erythro beta-substituted aspartates 178
Recognition and resistance in TEM beta-lactamase 172
Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases 171
Structures of FOX-4 cephamycinase in complex with transition-state analog inhibitors 168
Inhibition of the Class C β-Lactamase from Acinetobacter spp.: Insights into Effective Inhibitor Design 161
Structure-Based Design and In Parallel Synthesis of Boronic Acid Inhibitors of AmpC 61538;-Lactamase 156
α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs 154
Structure-based design and solid phase synthesis of novel AmpC b-lactamase inhibitors 153
Progettazione, Sintesi ed Attività di Acidi 1-Acilamminoalcanboronici Inibitori di beta-Lattamasi 149
Interactions of Oxyimino-Substituted Boronic Acids and β-Lactams with the CMY-2-Derived Extended-Spectrum Cephalosporinases CMY-30 and CMY-42 143
The role of a second-shell residue in modifying substrate and inhibitor interactions in the SHV β-lactamase: A study of Ambler position Asn276 143
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum 140
Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii 139
Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates 139
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML 131
Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog 130
Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor 127
Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry 102
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas-derived cephalosporinase 93
Structural Studies of Inhibition of β-Lactamases by Boronic Acid Transition State Analogs and a Penam Sulfone 91
Restoring cefepime activity against multidrug-resistant KPC-producing Klebsiella pneumoniae by combination with boronic acid inhibitors, MB076 and S02030 68
Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the Acinetobacter-derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant Acinetobacter baumannii (CRAb) 62
Boronate-Based Inhibitors of Penicillin-Binding Proteins: An Underestimated Avenue for Antibiotic Discovery? 58
Totale 14.523
Categoria #
all - tutte 54.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021769 0 0 0 0 0 0 119 139 124 201 107 79
2021/20221.248 81 116 86 106 68 109 48 88 144 88 187 127
2022/20231.532 186 174 113 161 173 222 38 120 180 20 55 90
2023/2024988 38 76 49 104 186 92 143 78 26 32 53 111
2024/20253.060 110 65 70 178 536 456 205 228 301 84 337 490
2025/20263.595 376 334 587 784 876 516 122 0 0 0 0 0
Totale 14.523